{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T20:05:33Z","timestamp":1779998733868,"version":"3.53.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32170939"],"award-info":[{"award-number":["32170939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32411540019"],"award-info":[{"award-number":["32411540019"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82371846"],"award-info":[{"award-number":["82371846"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012245","name":"Science and Technology Planning Project of Guangdong Province","doi-asserted-by":"publisher","award":["2021B1212030014"],"award-info":[{"award-number":["2021B1212030014"]}],"id":[{"id":"10.13039\/501100012245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A04J6161"],"award-info":[{"award-number":["2025A04J6161"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013050","name":"Guangdong Provincial Applied Science and Technology Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1515020075"],"award-info":[{"award-number":["2022B1515020075"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virologica Sinica"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.virs.2026.03.017","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:15:57Z","timestamp":1775135757000},"page":"404-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and characterization of neutralizing monoclonal antibodies against clinically relevant human adenovirus subgroup B serotypes"],"prefix":"10.1016","volume":"41","author":[{"given":"Yuelin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyuji","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yushan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladislav Victorovich","family":"Khrustalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey V.","family":"Churov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander N.","family":"Orekhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1414-4438","authenticated-orcid":false,"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0905-139X","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2196-2556","authenticated-orcid":false,"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8607-3750","authenticated-orcid":false,"given":"Chenguang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virs.2026.03.017_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1632","article-title":"Successful use of cidofovir in an immunocompetent child with severe adenoviral sepsis","volume":"145","author":"Alcamo","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.virs.2026.03.017_bib2","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.virs.2026.03.017_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib4","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1128\/JVI.06165-11","article-title":"Adenovirus serotype 5-specific neutralizing antibodies target multiple hexon hypervariable regions","volume":"86","author":"Bradley","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients' B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virs.2026.03.017_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01925-18","article-title":"Cidofovir diphosphate inhibits adenovirus 5 DNA polymerase via both nonobligate chain termination and direct inhibition, and polymerase mutations confer Cidofovir resistance on intact virus","volume":"63","author":"Chamberlain","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.virs.2026.03.017_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/jmv.21045","article-title":"A community-derived outbreak of adenovirus type 3 in children in Taiwan between 2004 and 2005","volume":"80","author":"Chang","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib8","article-title":"A humanized anti-human adenovirus 55 monoclonal antibody with good neutralization ability","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virs.2026.03.017_bib9","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.healun.2007.06.009","article-title":"Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients","volume":"26","author":"Doan","year":"2007","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.virs.2026.03.017_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/426594","article-title":"Intravesical instillation of cidofovir in the treatment of hemorrhagic cystitis caused by adenovirus type 11 in a bone marrow transplant recipient","volume":"40","author":"Fanourgiakis","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.017_bib11","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.virol.2018.03.002","article-title":"Hexon and fiber of adenovirus type 14 and 55 are major targets of neutralizing antibody but only fiber-specific antibody contributes to cross-neutralizing activity","volume":"518","author":"Feng","year":"2018","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.03.017_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12879-018-3651-2","article-title":"Human adenovirus type 7 infection causes a more severe disease than type 3","volume":"19","author":"Fu","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.virs.2026.03.017_bib13","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1128\/JVI.72.3.2388-2397.1998","article-title":"Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity","volume":"72","author":"Gah\u00e9ry-S\u00e9gard","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib14","doi-asserted-by":"crossref","first-page":"758","DOI":"10.12688\/f1000research.8374.2","article-title":"Use of cidofovir in pediatric patients with adenovirus infection","volume":"5","author":"Ganapathi","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.virs.2026.03.017_bib15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/biomedicines6010030","article-title":"The repertoire of adenovirus in human disease: the innocuous to the deadly","volume":"6","author":"Khanal","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.virs.2026.03.017_bib16","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41467-025-59301-4","article-title":"Molecular mechanisms of the viral encoded chaperone 100K in capsid folding and assembly of adenovirus","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virs.2026.03.017_bib17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1080\/22221751.2021.1895679","article-title":"Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B","volume":"10","author":"Li","year":"2021","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.03.017_bib18","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virs.2026.03.017_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2307513","article-title":"Neutralizing monoclonal antibodies protect against human adenovirus type 55 infection in transgenic mice and tree shrews","volume":"13","author":"Liu","year":"2024","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.03.017_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2019.12.005","article-title":"A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein","volume":"543","author":"Lu","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.virs.2026.03.017_bib21","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0031-1283287","article-title":"Adenovirus","volume":"32","author":"Lynch","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.virs.2026.03.017_bib22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.bbmt.2006.08.040","article-title":"Treatment of adenovirus disease in stem cell transplant recipients with cidofovir","volume":"13","author":"Neofytos","year":"2007","journal-title":"Biol. Blood Marrow Transplant."},{"key":"10.1016\/j.virs.2026.03.017_bib23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s13054-014-0456-6","article-title":"Emergent severe acute respiratory distress syndrome caused by adenovirus type 55 in immunocompetent adults in 2013: a prospective observational study","volume":"18","author":"Sun","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.virs.2026.03.017_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41426-018-0197-8","article-title":"Broadly neutralizing monoclonal antibodies against human adenovirus types 55, 14p, 7, and 11 generated with recombinant type 11 fiber knob","volume":"7","author":"Tian","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virs.2026.03.017_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.virusres.2013.08.013","article-title":"Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3","volume":"177","author":"Tian","year":"2013","journal-title":"Virus Res."},{"key":"10.1016\/j.virs.2026.03.017_bib26","doi-asserted-by":"crossref","first-page":"12320","DOI":"10.1128\/JVI.78.22.12320-12332.2004","article-title":"Postentry neutralization of adenovirus type 5 by an antihexon antibody","volume":"78","author":"Varghese","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.virs.2026.03.017_bib28","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1128\/jvi.62.7.2321-2328.1988","article-title":"Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms","volume":"62","author":"Wohlfart","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.virs.2026.03.017_bib29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.virs.2024.12.004","article-title":"Comparative analysis between genotypes of adenovirus isolates from hospitalized children with acute respiratory tract infections and clinical manifestations in Wuhan, China, from June 2022 to September 2023","volume":"40","author":"Wu","year":"2025","journal-title":"Virol. Sin."},{"key":"10.1016\/j.virs.2026.03.017_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12985-018-1037-0","article-title":"Human adenovirus load in respiratory tract secretions are predictors for disease severity in children with human adenovirus pneumonia","volume":"15","author":"Xie","year":"2018","journal-title":"Virol. J."},{"key":"10.1016\/j.virs.2026.03.017_bib31","first-page":"110","article-title":"Detection of respiratory viral and bacterial pathogens causing pediatric community-acquired pneumonia in Beijing using real-time PCR","volume":"1","author":"Zhang","year":"2015","journal-title":"Chronic Dis Transl Med"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1995820X26000544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T19:46:51Z","timestamp":1779997611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1995820X26000544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1995820X26000544"],"URL":"https:\/\/doi.org\/10.1016\/j.virs.2026.03.017","relation":{},"ISSN":["1995-820X"],"issn-type":[{"value":"1995-820X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of neutralizing monoclonal antibodies against clinically relevant human adenovirus subgroup B serotypes","name":"articletitle","label":"Article Title"},{"value":"Virologica Sinica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virs.2026.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}